Storage and handling
Consérvese a temperatura ambiente a no más de 30°C
Consérvese a temperatura ambiente a no más de 30°C
| Benzocaína | Anestésico de acción inmediata que calma el dolor al contacto. |
| Benzoína | Resina que forma una capa protectora a base de polímeros que se adhiere a la lesión. |
Fórmula. Cada 100 ml contienen:
| Benzocaína | 20 g |
| Tintura de Benzoína | 0.5 g |
| Vehículo cbp | 100 ml |
KANK-A® es un anestésico bucal, auxiliar en el tratamiento de las ulceraciones bucales.
KANK-A® contiene Benzocaína y compuesto de tintura de Benzoína alivia el dolor y la irritación.
Aplicar la solución sobre el área lastimada con ayuda del aplicador que esta integrado a la tapa.
Aplicar una pequeña cantidad cada 4 horas. De ser necesario se puede aplicar con una frecuencia de hasta 2 horas.
No se use en el embarazo y lactancia.
Hipersensibilidad a los componentes de la fórmula, no usarse por períodos de más de 7 días.
Este producto contiene Benzocaína y puede causar alergias. Por lo que se recomienda realizar un examen, aplicando una pequeña cantidad de producto en la parte interna del labio, antes de usarlo en un área más extensa.
Si no observa mejoría en el transcurso de 72 horas o se presenta inflamación, suspenda su uso y consulte a su médico.
No se deje al alcance de los niños.
Consérvese a temperatura ambiente a no más de 30°C
Distribuido por: Laboratorios Sanfer,
S.A. de C.V., Hormona No. 2-A,
San Andrés Atoto, Naucalpan
de Juárez, México, 53500
ALIVIO PROFESIONAL
DEL DOLOR BUCAL
Blistex®
KANK A®
BENZOCAÍNA-BENZOÍNA
Solución
MEDICAMENTO
PARA LAS AFTAS
Alivio del dolor
Forma una película protectora
Para las úlceras en la boca:
Contenido neto: 9.7ml
INCLUYE
APLICADOR

| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 199035 | benzocaine 20 % / compound benzoin tincture 0.5 % Mucous Membrane Topical Solution | PSN | 1 |
| 199035 | benzocaine 200 MG/ML / compound benzoin tincture (USP) 5 MG/ML Mucous Membrane Topical Solution | SCD | 1 |
| 199035 | benzocaine 20 % / compound benzoin tincture (USP) 0.5 % Mucous Membrane Topical Solution | SY | 1 |
| Class | Version | Type | Effective |
|---|---|---|---|
| BENZOCAINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 10157-9410-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-b1c1-f424-e053-dadaa90a57ce | Blistex ® Kank-A ® Liquid |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 10157-9410-2 | Blistex Kank-A | 9.7 mL in 1 BOTTLE, WITH APPLICATOR | LIQUID | 9.7 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 10157-9410 | BLISTEX KANK-A (BENZOCAINE AND BENZOIN RESIN) LIQUID [BLISTEX INC.] | 1 | 1 package rows | 20150129_fe1e32e8-ec36-4d1f-b3e4-913dbc852138.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Benzocaine | ACTIVE INGREDIENT | U3RSY48JW5 | 1 | |
| BENZOIN RESIN | ACTIVE INGREDIENT | GK21SBA74R | 1 | |
| Benzocaine | ACTIVE MOIETY | U3RSY48JW5 | 1 | |
| BENZOIN RESIN | ACTIVE MOIETY | GK21SBA74R | 1 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| benzyl alcohol | INACTIVE INGREDIENT | LKG8494WBH | 1 | |
| CASTOR OIL | INACTIVE INGREDIENT | D5340Y2I9G | 1 | |
| cetylpyridinium chloride | INACTIVE INGREDIENT | D9OM4SK49P | 1 | |
| dimethyl isosorbide | INACTIVE INGREDIENT | SA6A6V432S | 1 | |
| ethylcelluloses | INACTIVE INGREDIENT | 7Z8S9VYZ4B | 1 | |
| oleth-10 | INACTIVE INGREDIENT | JD797EF70J | 1 | |
| POLYETHYLENE GLYCOL 300 | INACTIVE INGREDIENT | 5655G9Y8AQ | 1 | |
| propylene glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | 1 | |
| saccharin | INACTIVE INGREDIENT | FST467XS7D | 1 | |
| tannic acid | INACTIVE INGREDIENT | 28F9E0DJY6 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 10157-9410 | 10157-9410-2 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Benzocaine | U3RSY48JW5 | ACTIB |
| BENZOIN RESIN | GK21SBA74R | ACTIB |
| ALCOHOL | 3K9958V90M | IACT |
| POLYETHYLENE GLYCOL 300 | 5655G9Y8AQ | IACT |
| propylene glycol | 6DC9Q167V3 | IACT |
| tannic acid | 28F9E0DJY6 | IACT |
| dimethyl isosorbide | SA6A6V432S | IACT |
| benzyl alcohol | LKG8494WBH | IACT |
| oleth-10 | JD797EF70J | IACT |
| CASTOR OIL | D5340Y2I9G | IACT |
| saccharin | FST467XS7D | IACT |
| ethylcelluloses | 7Z8S9VYZ4B | IACT |
| cetylpyridinium chloride | D9OM4SK49P | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION/ DROPS / AURICULAR (OTIC) | ADJ PH | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, FOAM / VAGINAL | 6.4 %w/w | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | INJECTION, SUSPENSION / INTRAMUSCULAR | 40 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, METERED / RECTAL | NA | ||
| cetylpyridinium chloride | CETYLPYRIDINIUM CHLORIDE | D9OM4SK49P | CAPSULE, EXTENDED RELEASE / ORAL | 0.02 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 144 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, SOLUTION / INTRAMUSCULAR | 4000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| saccharin | SACCHARIN | FST467XS7D | POWDER, FOR SOLUTION / ORAL | NA | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY | 8.4 mg | ||
| saccharin | SACCHARIN | FST467XS7D | DROPS / ORAL | 20 mg/1ml | ||
| saccharin | SACCHARIN | FST467XS7D | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 0.05 %w/w | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, EXTENDED RELEASE / ORAL | 9 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / OPHTHALMIC | 1 %w/v | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | INJECTION, SUSPENSION / INTRASYNOVIAL | 18 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / AURICULAR (OTIC) | 56.55 %w/v | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | INJECTION, SUSPENSION / INTRALESIONAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, SOLUTION / INTRAVENOUS | 4000 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION/ DROPS / OPHTHALMIC | 0.75 %w/v | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | TABLET, DELAYED RELEASE / ORAL | 2.31 mg | ||
| saccharin | SACCHARIN | FST467XS7D | SYRUP / ORAL | 8 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | EMULSION / OPHTHALMIC | 32 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | INJECTION, SOLUTION / INTRAMUSCULAR | 525 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | CAPSULE / ORAL | 1.04 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL / TOPICAL | 19.2 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | LIQUID / RESPIRATORY (INHALATION) | 10 %w/w | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | GRANULE, FOR SUSPENSION / ORAL | 128 mg | ||
| POLYETHYLENE GLYCOL 300 | POLYETHYLENE GLYCOL 300 | 5655G9Y8AQ | DROPS / AURICULAR (OTIC) | 97.43 %w/w | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | GEL / VAGINAL | 100 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | TAMPON / VAGINAL | 62.1 mg | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | INJECTION, SOLUTION / INTRA-ARTICULAR | 23 mg | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | GEL / RECTAL | 124 mg | ||
| saccharin | SACCHARIN | FST467XS7D | GRANULE, FOR SOLUTION / ORAL | 16 mg | ||
| saccharin | SACCHARIN | FST467XS7D | TABLET, CHEWABLE / ORAL | 0.9 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, FOAM / TOPICAL | 1800 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / RECTAL | 27 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | TABLET / ORAL | 1.06 mg | ||
| saccharin | SACCHARIN | FST467XS7D | TABLET / SUBLINGUAL | 0.2 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM / BUCCAL | 1.48 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, DELAYED RELEASE / ORAL | 1.7 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION / INTRAVENOUS | 16624 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / RECTAL | 3315 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | TABLET, DELAYED RELEASE / ORAL | 0.01 mg | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | SUSPENSION / ORAL | 100 mg | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | SUSPENSION / TOPICAL | 1 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| POLYETHYLENE GLYCOL 300 | POLYETHYLENE GLYCOL 300 | 5655G9Y8AQ | SOLUTION / INTRAVENOUS | 16920 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / ORAL | 22602 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| saccharin | SACCHARIN | FST467XS7D | OINTMENT / TOPICAL | 0.5 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| d7fdef05-a243-4b79-a858-0e458c54e775 | fe1e32e8-ec36-4d1f-b3e4-913dbc852138 | 2015-01-22 | Warnings | d7fdef05-a243-4b79-a858-0e458c54e775 fe1e32e8-ec36-4d1f-b3e4-913dbc852138 |
Adverse event summaries are temporarily unavailable. Other product information remains available.